Comparison of Robenacoxib and carprofen in palliative management of cancer pain.
Hoeven, L.M.A. van der
MetadataShow full item record
When dogs with cancer are no longer (or not at all) treated for their illness, a palliative treatment should be given to increase the wellbeing of the dog. Dogs express pain in many different ways, sometimes by very subtle changes in behaviour. A brochure was created to inform owners about dogs that suffer from pain due to cancer and how to recognize this pain. A blinded cross-over study was performed on 6 dogs with untreated tumors comparing Robenacoxib and carporal as a palliative therapy. These two NSAIDs were compared using three forms (scoring pain, quality of life and adverse events), filled in weekly by the owners of the dogs. During 4 weeks every dog received either carprofen or Robenacoxib, they then had a wash-out period of one day without pain medication. Subsequently the other medication (either Robenacoxib or carprofen) was given during the next 4 weeks. When looking at the interim results, using a paired samples t-test and an independent samples t-test no significant differences between the two medications were found. Further research by examining more dogs is necessary to obtain more data. It is important to see whether or not a significant difference could be acquired between the medications in the future.